Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprim-sulfamethoxazole treatment.

× No keyword cloud information.

12 in total

1. Methotrexate-induced pancytopenia associated with co-prescription of penicillin and trimethoprim.

Authors: Navtej Sathi; Julie Dawson
Journal: Clin Rheumatol Date: 2006-08-29 Impact factor: 2.980

2. Clinical characteristics related to methotrexate-induced pancytopenia.

Authors: Y Ohosone; Y Okano; H Kameda; N Hama; T Mimori; M Akizuki; Y Ikeda
Journal: Clin Rheumatol Date: 1997-05 Impact factor: 2.980

3. Methotrexate and trimethoprim-sulfamethoxazole: toxicity from this combination continues to occur.

Authors: Jessica Cudmore; Matthew Seftel; Jeffrey Sisler; Ryan Zarychanski
Journal: Can Fam Physician Date: 2014-01 Impact factor: 3.275

Review 4. Pharmacological therapy for Wegener's granulomatosis.

Authors: Eric S White; Joseph P Lynch
Journal: Drugs Date: 2006 Impact factor: 9.546

5. Fatal outcome of low-dose methotrexate therapy in rheumatoid arthritis.

Authors: R Omdal; L Gøransson; H Bergrem
Journal: Clin Rheumatol Date: 1993-06 Impact factor: 2.980

6. Use of methotrexate in older patients. A risk-benefit assessment.

Authors: S E Tett; E J Triggs
Journal: Drugs Aging Date: 1996-12 Impact factor: 3.923

Review 7. Slow-acting antirheumatic drugs. Drug interactions of clinical significance.

Authors: R A Munro; R D Sturrock
Journal: Drug Saf Date: 1995-07 Impact factor: 5.606

Review 8. Antineoplastic agents. Drug interactions of clinical significance.

Authors: E van Meerten; J Verweij; J H Schellens
Journal: Drug Saf Date: 1995-03 Impact factor: 5.606

9. Safety of the concomitant use of methotrexate and a prophylactic dose of trimethoprim-sulfamethoxazole.

Authors: Oh Chan Kwon; Jung Sun Lee; Yong-Gil Kim; Chang-Keun Lee; Bin Yoo; Seokchan Hong
Journal: Clin Rheumatol Date: 2018-01-30 Impact factor: 2.980

Review 10. Methotrexate in rheumatoid arthritis. An update.

Authors: B Bannwarth; L Labat; Y Moride; T Schaeverbeke
Journal: Drugs Date: 1994-01 Impact factor: 9.546